Publicaciones en colaboración con investigadores/as de National Cancer Institute (56)

2023

  1. Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: An international multicentre analysis

    CMAJ. Canadian Medical Association Journal, Vol. 66, Núm. 3, pp. E310-E320

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2020

  1. Prognostic gene expression signature for high-grade serous ovarian cancer

    Annals of Oncology, Vol. 31, Núm. 9, pp. 1240-1250

2016

  1. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer

    Clinical Cancer Research, Vol. 21, Núm. 3, pp. 652-657

  2. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

    Nature Genetics, Vol. 47, Núm. 2, pp. 164-171

2014

  1. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

    Haematologica, Vol. 99, Núm. 7, pp. 1228-1235

2013

  1. Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival

    Molecular and Cellular Biology, Vol. 33, Núm. 22, pp. 4562-4578

  2. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2010

  1. Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection

    Cytometry Part B - Clinical Cytometry

  2. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1

  3. International network of cancer genome projects

    Nature, Vol. 464, Núm. 7291, pp. 993-998

  4. Prevalence of monoclonal B-cell lymphocytosis: A systematic review

    Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1

2008

  1. Flow cytometric immunophenotyping of cerebrospinal fluid

    Current Protocols in Cytometry

2007

  1. 2006 Bethesda international consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications

    Cytometry Part B - Clinical Cytometry

2004

  1. Genetics and Cytogenetics of Multiple Myeloma: A Workshop Report

    Cancer Research

2000

  1. The Sos1 and Sos2 Ras-specific exchange factors: Differences in placental expression and signaling properties

    EMBO Journal, Vol. 19, Núm. 4, pp. 642-654